Visium Technologies corrects claim CFO extended cure period before original filing
VISM•Visium Technologies said Mark B. Lucky had not extended the cure period for his Good Reason notice. His November 2 letter suspended it pending an independent committee, and the company said the period ends 30 days after the committee is constituted.
1. Cure period clarified
Visium Technologies corrected its October 30, 2026, disclosure, saying CFO Mark B. Lucky had not extended the cure period for his Good Reason notice. His November 2 letter suspended the period pending an independent committee; it ends 30 days after the committee is constituted. Lucky’s resignation takes effect no later than March 1, 2027, if the matter remains unresolved, but he has not resigned.
2. Financial statements
In response to former CEO Paul R. Taylor, the company reiterated that its board had not concluded previously issued financial statements were unreliable.
